Exhibit 99.1
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
| | As of | |
| | March 31, 2023 | | | September 30, 2022 | |
ASSETS | | | | | | |
CURRENT ASSETS | | | | | | | | |
Cash | | $ | 542,272 | | | $ | 840,861 | |
Accounts receivable, net | | | 9,260,407 | | | | 6,784,307 | |
Inventories, net | | | 1,803,374 | | | | 1,722,120 | |
Advance to suppliers, net | | | 7,644,920 | | | | 4,091,990 | |
Acquisition deposit | | | 1,000,000 | | | | 1,000,000 | |
Prepaid expenses and other current assets | | | 3,967,756 | | | | 277,509 | |
TOTAL CURRENT ASSETS | | | 24,218,729 | | | | 14,716,787 | |
| | | | | | | | |
Property, plant and equipment, net | | | 22,135,274 | | | | 21,624,437 | |
Intangible assets, net | | | 373,751 | | | | 366,167 | |
Right-of-use lease assets, net | | | 450,282 | | | | 546,690 | |
Deferred tax assets, net | | | 29,023 | | | | 2,768 | |
TOTAL ASSETS | | $ | 47,207,059 | | | $ | 37,256,849 | |
| | | | | | | | |
LIABILITIES AND EQUITY | | | | | | | | |
CURRENT LIABILITIES | | | | | | | | |
Short-term loans | | $ | 2,666,457 | | | $ | 2,424,587 | |
Current portion of long-term loans | | | 1,934,411 | | | | 2,135,979 | |
Accounts payable | | | 324,240 | | | | 214,585 | |
Due to related parties | | | 120,203 | | | | 72,836 | |
Taxes payable | | | 1,676,714 | | | | 1,239,708 | |
Deferred revenue | | | 989,027 | | | | 188,745 | |
Accrued expenses and other current liabilities | | | 3,503,550 | | | | 114,431 | |
Finance lease liabilities, current | | | - | | | | 26,285 | |
Operating lease liability, current | | | 247,397 | | | | 230,182 | |
TOTAL CURRENT LIABILITIES | | | 11,461,999 | | | | 6,647,338 | |
| | | | | | | | |
Long-term loans | | | 30,336 | | | | 189,813 | |
Operating lease liability, noncurrent | | | 212,955 | | | | 327,202 | |
TOTAL LIABILITIES | | $ | 11,705,290 | | | $ | 7,164,353 | |
| | | | | | | | |
COMMITMENTS AND CONTINGENCIES | | | | | | | | |
EQUITY | | | | | | | | |
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 11,146,226 and 8,396,226 shares issued and outstanding as of March 31, 2023 and September 30, 2022, respectively | | | 1,115 | | | | 840 | |
Additional paid in capital | | | 17,946,174 | | | | 15,711,450 | |
Statutory reserve | | | 1,804,116 | | | | 1,804,116 | |
Retained earnings | | | 16,796,529 | | | | 14,676,769 | |
Accumulated other comprehensive income | | | (1,559,550 | ) | | | (2,631,171 | ) |
TOTAL BON NATURAL LIFE LIMITED SHAREHOLDERS’ EQUITY | | | 34,988,384 | | | | 29,562,004 | |
Non-controlling interest | | | 513,387 | | | | 530,492 | |
TOTAL SHAREHOLDERS’ EQUITY | | | 35,501,771 | | | | 30,092,496 | |
TOTAL LIABILITIES AND EQUITY | | $ | 47,207,059 | | | $ | 37,256,849 | |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(UNAUDITED)
| | For the six months ended March 31, | |
| | 2023 | | | 2022 | |
REVENUE | | $ | 14,149,967 | | | $ | 13,688,400 | |
COST OF REVENUE | | | (9,432,619 | ) | | | (9,652,453 | ) |
GROSS PROFIT | | | 4,717,348 | | | | 4,035,947 | |
| | | | | | | | |
OPERATING EXPENSES | | | | | | | | |
Selling expenses | | | (136,164 | ) | | | (83,970 | ) |
General and administrative expenses | | | (1,465,955 | ) | | | (998,943 | ) |
Research and development expenses | | | (129,995 | ) | | | (164,675 | ) |
Total operating expenses | | | (1,732,114 | ) | | | (1,247,588 | ) |
| | | | | | | | |
INCOME FROM OPERATIONS | | | 2,985,234 | | | | 2,788,359 | |
| | | | | | | | |
OTHER INCOME (EXPENSES) | | | | | | | | |
Interest income | | | 8,732 | | | | 589 | |
Interest expense | | | (178,557 | ) | | | (277,764 | ) |
Unrealized foreign transaction exchange loss | | | 8,452 | | | | (16,994 | ) |
Government subsidies | | | 11,916 | | | | 542,256 | |
Income from short-term investments | | | - | | | | 12,419 | |
Other income | | | (223,043 | ) | | | 43,532 | |
Total other income, net | | | (372,501 | ) | | | 304,038 | |
| | | | | | | | |
INCOME BEFORE INCOME TAX PROVISION | | | 2,617,733 | | | | 3,092,397 | |
| | | | | | | | |
INCOME TAX PROVISION | | | (510,077 | ) | | | (562,737 | ) |
| | | | | | | | |
NET INCOME | | | 2,102,656 | | | | 2,529,660 | |
Less: net loss attributable to non-controlling interest | | | (17,104 | ) | | | (19,018 | ) |
NET INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED | | $ | 2,119,760 | | | $ | 2,548,678 | |
| | | | | | | | |
NET INCOME | | | 2,102,656 | | | | 2,529,660 | |
| | | | | | | | |
OTHER COMPREHENSIVE INCOME | | | | | | | | |
Total foreign currency translation adjustment | | | 1,071,621 | | | | 485,503 | |
TOTAL COMPREHENSIVE INCOME | | | 3,174,277 | | | | 3,015,163 | |
Less: comprehensive loss attributable to non-controlling interest | | | (17,104 | ) | | | (21,314 | ) |
COMPREHENSIVE INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED | | $ | 3,191,381 | | | $ | 3,036,477 | |
| | | | | | | | |
EARNINGS PER SHARE | | | | | | | | |
Basic | | $ | 0.24 | | | $ | 0.31 | |
Diluted | | $ | 0.24 | | | $ | 0.30 | |
| | | | | | | | |
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING | | | | | | | | |
Basic | | | 8,918,309 | | | | 8,350,381 | |
Diluted | | | 8,979,243 | | | | 8,386,306 | |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE SIX MONTHS ENDED MARCH 31, 2023 AND 2022
(UNAUDITED)
| | Common shares | | | Additional paid-in | | | Statutory | | | Retained | | | Accumulated other comprehensive | | | Total shareholders’ | | | Non- controlling | | | Total | |
| | Shares | | | Amount | | | capital | | | reserve | | | earnings | | | loss | | | equity | | | interest | | | equity | |
Balance at September 30, 2021 | | | 8,330,000 | | | $ | 833 | | | $ | 15,540,433 | | | $ | 1,050,721 | | | $ | 9,192,676 | | | $ | 222,221 | | | $ | 26,006,884 | | | $ | 527,865 | | | $ | 26,534,749 | |
Non-cash exercise of warrants | | | 20,381 | | | | 2 | | | | (2 | ) | | | - | | | | - | | | | - | | | | - | | | | - | | | | - | |
Amortization of share-based compensation | | | - | | | | - | | | | 89,820 | | | | - | | | | - | | | | - | | | | 89,820 | | | | - | | | | 89,820 | |
Net income (loss) | | | - | | | | - | | | | - | | | | - | | | | 2,548,678 | | | | - | | | | 2,548,678 | | | | (19,018 | ) | | | 2,529,660 | |
Foreign currency translation adjustment | | | - | | | | - | | | | - | | | | - | | | | - | | | | 487,799 | | | | 487,799 | | | | (2,296 | ) | | | 485,503 | |
Balance at March 31, 2022 | | | 8,350,381 | | | $ | 835 | | | $ | 15,630,251 | | | $ | 1,050,721 | | | $ | 11,741,354 | | | $ | 710,020 | | | $ | 29,133,181 | | | $ | 506,551 | | | $ | 29,639,732 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at September 30, 2022 | | | 8,396,226 | | | $ | 840 | | | $ | 15,711,450 | | | $ | 1,804,116 | | | $ | 14,676,769 | | | $ | (2,631,171 | ) | | $ | 29,562,004 | | | $ | 530,492 | | | $ | 30,092,496 | |
Issuance of ordinary shares in initial public offerings, net | | | 2,750,000 | | | | 275 | | | | 2,199,725 | | | | - | | | | - | | | | - | | | | 2,200,000 | | | | - | | | | 2,200,000 | |
Amortization of stock options | | | - | | | | - | | | | 35,000 | | | | - | | | | | | | | - | | | | 35,000 | | | | - | | | | 35,000 | |
Net income (loss) | | | - | | | | -- | | | | - | | | | - | | | | 2,119,760 | | | | - | | | | 2,119,760 | | | | (17,104 | ) | | | 2,102,656 | |
Foreign currency translation adjustment | | | - | | | | - | | | | | | | | - | | | | - | | | | 1,071,621 | | | | 1,071,621 | | | | - | | | | 1,071,621 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at March 31, 2023 | | | 11,146,226 | | | $ | 1,115 | | | $ | 17,946,175 | | | $ | 1,804,116 | | | $ | 16,796,529 | | | $ | (1,559,550 | ) | | $ | 34,988,384 | | | $ | 513,387 | | | $ | 35,501,771 | |
BON NATURAL LIFE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| | For the six months ended March 31, | |
| | 2023 | | | 2022 | |
Cash flows from operating activities | | | | | | | | |
Net income | | $ | 2,102,656 | | | $ | 2,529,660 | |
Adjustments to reconcile net income to cash provided by operating activities | | | | | | | | |
Allowance for doubtful accounts | | | - | | | | 187 | |
Depreciation and amortization | | | 282,888 | | | | 112,945 | |
Inventory reserve | | | 105,314 | | | | - | |
Deferred income tax | | | (25,749 | ) | | | (28 | ) |
Amortization of operating lease right-of-use assets | | | 114,179 | | | | 33,122 | |
Amortization of stock options | | | 35,000 | | | | 89,820 | |
Unrealized foreign currency exchange loss | | | (8,452 | ) | | | 16,994 | |
Gain on disposal of property and equipment | | | - | | | | (745 | ) |
Changes in operating assets and liabilities: | | | | | | | | |
Accounts receivable | | | (2,198,450 | ) | | | (1,265,109 | ) |
Inventories | | | (124,601 | ) | | | (515,690 | ) |
Advance to suppliers, net | | | (3,353,433 | ) | | | 977,033 | |
Prepaid expenses and other current assets | | | (3,595,458 | ) | | | (38,795 | ) |
Accounts payable | | | 100,386 | | | | 165,741 | |
Operating lease liabilities | | | (115,170 | ) | | | (30,589 | ) |
Taxes payable | | | 386,510 | | | | (1,806,543 | ) |
Deferred revenue | | | 781,183 | | | | (440,032 | ) |
Accrued expenses and other current liabilities | | | 3,335,205 | | | | 41,452 | |
Net cash used in operating activities | | | (2,177,992 | ) | | | (130,577 | ) |
| | | | | | | | |
Cash flows from investing activities | | | | | | | | |
Purchase of short-term investments | | | - | | | | (3,678,199 | ) |
Proceeds upon redemption of short-term investments | | | - | | | | 5,273,186 | |
Purchase of property and equipment | | | (15,131 | ) | | | (10,231 | ) |
Proceeds from sales of property and equipment | | | - | | | | 1,659 | |
Capital expenditures on construction-in-progress | | | (2,970 | ) | | | (3,577,995 | ) |
Net cash used in investing activities | | | (18,101 | ) | | | (1,991,580 | ) |
| | | | | | | | |
Cash flows from financing activities | | | | | | | | |
Net proceeds from issuance of Ordinary Shares in initial public offerings | | | 2,200,000 | | | | - | |
Proceeds from short-term loans | | | 259,767 | | | | 1,608,378 | |
Proceeds from long-term loans | | | - | | | | 594,864 | |
Repayment of short-term loans | | | (79,165 | ) | | | (41,945 | ) |
Repayment of long-term loans | | | (437,412 | ) | | | (339,343 | ) |
Proceeds from (repayment of) borrowings from related parties | | | (1,038 | ) | | | 91,965 | |
Principal repayment of capital lease | | | (27,236 | ) | | | (89,465 | ) |
Net cash provided by financing activities | | | 1,914,916 | | | | 1,824,454 | |
| | | | | | | | |
Effect of changes of foreign exchange rates on cash | | | (17,412 | ) | | | 2,915 | |
Net decrease in cash | | | (298,589 | ) | | | (294,788 | ) |
Cash, beginning of period | | | 840,861 | | | | 1,903,867 | |
Cash, end of period | | $ | 542,272 | | | $ | 1,609,079 | |
| | | | | | | | |
Supplemental disclosure of cash flow information | | | | | | | | |
Cash paid for interest expense | | $ | 178,557 | | | $ | 277,764 | |
Cash paid for income tax | | $ | 500,251 | | | $ | 785,853 | |
Supplemental disclosure of non-cash investing and financing activities | | | | | | | | |
Amortization of share-based compensation for initial public offering services | | $ | 35,000 | | | $ | 89,820 | |
Right-of-use assets obtained in exchange for operating lease obligations | | $ | 458,181 | | | $ | - | |